603259.SS · 药明康德
China A-shares · RS rating 97 · As of 2026-10-14
| Price | 154.18 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 79 / 93 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 51 / 44 |
| Industry group (rank) | Medical-Diversified (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +32.4% |
| Distance from 52-week high | +8.2% |
| Market cap (USD) | $73.5B |